Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

@inproceedings{Nishii2014ClinicopathologicalFA,
  title={Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer},
  author={Teppei Nishii and Tomoyuki Yokose and Yohei Miyagi and Yataro Daigo and Hiroyuki Ito and Tetsuya Isaka and Kentaro Imai and Shuji Murakami and Tetsuro Kondo and Haruhiro Saito and Fumihiro Oshita and Kouzo Yamada and Shoichi Matsukuma and Masahiro Tsuboi and Haruhiko Nakayama and Munetaka Masuda},
  booktitle={BMC Cancer},
  year={2014}
}
The rapid aging of the population in Japan has been accompanied by an increased rate of surgery for lung cancer among elderly patients. It is thus an urgent priority to map out a treatment strategy for elderly patients with primary lung cancer. Although surgical resection remains standard treatment for early stage non–small-cell lung cancer (NSCLC), it is now essential to confirm the status of epidermal growth factor receptor (EGFR) gene mutations when planning treatment strategies. Furthermore… CONTINUE READING